New Key Statistics Module, Z-Score and F-Score
NAS:LIFE Key Ratios
| Market Cap $ M | 108.70 |
| Enterprise Value $ M | 26.99 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.12 |
| Price/Sales | 270.00 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -0.96 |
| Beneish M-Score | -4.1 |
| 10-y EBITDA Growth Rate % | 33.90 |
| 5-y EBITDA Growth Rate % | 39.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.49 |
| EV-to-EBITDA | -0.52 |
| PEG | -- |
| Shares Outstanding M | 67.94 |
| Net Margin (%) | -14,274.50 |
| Operating Margin % | -15,557.79 |
| Pre-tax Margin (%) | -14,276.77 |
| Quick Ratio | 6.27 |
| Current Ratio | 6.27 |
| ROA % (ttm) | -41.23 |
| ROE % (ttm) | -52.86 |
| ROIC % (ttm) | -297.71 |
| Dividend Yield % | -- |
| Altman Z-Score | -3.76 |
LIFE Number of Guru Trades
LIFE Volume of Guru Trades
Gurus Latest Trades with NAS:LIFE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:LIFE is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
aTyr Pharma Inc Insider Transactions
No Available Data
News about NAS:LIFE
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers